Aclaris Therapeutics, Inc. Revenue 2017–2025
Aclaris Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Aclaris Therapeutics, Inc. revenue for the quarter ending March 31, 2026 was 2.0 M, a 37.18% increase year-over-year.
- Aclaris Therapeutics, Inc. revenue for the twelve months ending March 31, 2026 was 8.5 M, a 54.62% decrease year-over-year.
- Aclaris Therapeutics, Inc. annual revenue for 2025 was 7.8 M, a 58.19% decrease from 2024.
- Aclaris Therapeutics, Inc. annual revenue for 2024 was 18.7 M, a 40.09% decrease from 2023.
- Aclaris Therapeutics, Inc. annual revenue for 2023 was 31.2 M, a 5.03% increase from 2022.
- Aclaris Therapeutics, Inc. annual revenue for 2022 was 29.8 M.
Aclaris Therapeutics, Inc. (ACRS) — Frequently Asked Questions
Aclaris Therapeutics, Inc. (ACRS) is a publicly traded US company. It has a market capitalization of $526M. In fiscal 2025 it reported revenue of $8M and net income of -$65M. Explore ACRS's stock price, financial statements, earnings history, margins and key ratios below.
What is Aclaris Therapeutics, Inc.'s market cap?
Aclaris Therapeutics, Inc. (ACRS) has a market capitalization of $526M.
What is the ACRS stock price?
ACRS trades at $4.29 (+4.63% on the day).
How much revenue does Aclaris Therapeutics, Inc. make?
Aclaris Therapeutics, Inc. reported revenue of $8M in fiscal 2025.
Is ACRS profitable?
In fiscal 2025, Aclaris Therapeutics, Inc. reported net income of -$65M.